USA Law

Tag: Drugs

  • Other Federal Programs

    In Legislation Other Federal Programs in the U.S. Code: Title 21, Chapter 16, Subchapter IV The current, permanent, in-force federal laws regulating other federal programs are compiled in the United States Code under Title 21, Chapter 16, Subchapter IV. It constitutes "prima facie" […]

  • Other Federal Programs

    In Legislation Other Federal Programs in the U.S. Code: Title 21, Chapter 16, Subchapter IV The current, permanent, in-force federal laws regulating other federal programs are compiled in the United States Code under Title 21, Chapter 16, Subchapter IV. It constitutes "prima facie" […]

  • Cosmetics

    In Legislation Cosmetics in the U.S. Code: Title 21, Chapter 9, Subchapter VI The current, permanent, in-force federal laws regulating cosmetics are compiled in the United States Code under Title 21, Chapter 9, Subchapter VI. It constitutes "prima facie" evidence of statutes […]

  • Cosmetics

    In Legislation Cosmetics in the U.S. Code: Title 21, Chapter 9, Subchapter VI The current, permanent, in-force federal laws regulating cosmetics are compiled in the United States Code under Title 21, Chapter 9, Subchapter VI. It constitutes "prima facie" evidence of statutes […]

  • Manufacture of Narcotic Drugs

    In Legislation Manufacture of Narcotic Drugs in the U.S. Code: Title 21, Chapter 11 The current, permanent, in-force federal laws regulating manufacture of narcotic drugs are compiled in the United States Code under Title 21, Chapter 11. It constitutes "prima facie" evidence of […]

  • Manufacture of Narcotic Drugs

    In Legislation Manufacture of Narcotic Drugs in the U.S. Code: Title 21, Chapter 11 The current, permanent, in-force federal laws regulating manufacture of narcotic drugs are compiled in the United States Code under Title 21, Chapter 11. It constitutes "prima facie" evidence of […]

  • Import and Export

    In Legislation Import and Export in the U.S. Code: Title 21, Chapter 13, Subchapter II The current, permanent, in-force federal laws regulating import and export are compiled in the United States Code under Title 21, Chapter 13, Subchapter II. It constitutes "prima facie" evidence […]

  • Colors

    In Legislation Colors in the U.S. Code: Title 21, Chapter 9, Subchapter VII, Part B The current, permanent, in-force federal laws regulating colors are compiled in the United States Code under Title 21, Chapter 9, Subchapter VII, Part B. It constitutes "prima facie" evidence of […]

  • Viruses, Serums, Toxins, Antitoxins, and Analogous Products

    In Legislation Viruses, Serums, Toxins, Antitoxins, and Analogous Products in the U.S. Code: Title 21, Chapter 5 The current, permanent, in-force federal laws regulating viruses, serums, toxins, antitoxins, and analogous products are compiled in the United States Code under Title 21, Chapter […]

  • Tobacco Products

    Tobacco Products (Consumer Protection) This section introduces, discusses and describes the basics of tobacco products. Then, cross references and a brief overview about Consumer Protection is provided. Finally, the subject of Antitrust, Trade Law in relation with tobacco products is examined. […]

  • Fees Relating to Outsourcing Facilities

    In Legislation Fees Relating to Outsourcing Facilities in the U.S. Code: Title 21, Chapter 9, Subchapter VII, Part C, Subpart 9 The current, permanent, in-force federal laws regulating fees relating to outsourcing facilities are compiled in the United States Code under Title 21, Chapter 9, […]

  • Fees Relating to Generic Drugs

    In Legislation Fees Relating to Generic Drugs in the U.S. Code: Title 21, Chapter 9, Subchapter VII, Part C, Subpart 7 The current, permanent, in-force federal laws regulating fees relating to generic drugs are compiled in the United States Code under Title 21, Chapter 9, Subchapter VII, Part […]

  • Serious Adverse Event Reports

    In Legislation Serious Adverse Event Reports in the U.S. Code: Title 21, Chapter 9, Subchapter VII, Part H The current, permanent, in-force federal laws regulating serious adverse event reports are compiled in the United States Code under Title 21, Chapter 9, Subchapter VII, Part H. It […]

  • Anti-doping Agency

    In Legislation Anti-doping Agency in the U.S. Code: Title 21, Chapter 25, Subchapter I The current, permanent, in-force federal laws regulating anti-doping agency are compiled in the United States Code under Title 21, Chapter 25, Subchapter I. It constitutes "prima facie" evidence […]

  • Information and Education

    In Legislation Information and Education in the U.S. Code: Title 21, Chapter 9, Subchapter VII, Part D The current, permanent, in-force federal laws regulating information and education are compiled in the United States Code under Title 21, Chapter 9, Subchapter VII, Part D. It constitutes […]